Emergent BioSolutions Inc. (EBS) analyst actions
Rating and price-target actions on EBS in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the EBS overview →
2 measured EBS analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Emergent BioSolutions Inc. (EBS) And Encourages Shareholders to Reach Out | Press release | +0.00% | +0.55% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Emergent BioSolutions Inc. (EBS) And Encourages Stockholders to Reach Out | Press release | -0.46% | +3.68% |
Keep exploring
More EBS: earnings → · SEC filings → · EBS overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Teleflex Incorporated (TFX) | 460 | -0.02% | 49% |
| CAS MEDICAL SYSTEMS (CASM) | 459 | 0.00% | 35% |
| REXAHN PHARMACEUTICALS (RNN) | 458 | -0.35% | 41% |
| NUVECTRA CORP COMMON (NVTR) | 456 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.